Cord Blood Banking Is The Fastest Growing Segment Fueling Growth Of Allogeneic Stem Cell Transplantation Market


https://www.coherentmarketinsights.com/industry-reports/allogeneic-stem-cell-transplantation-market
Allogeneic Stem Cell Transplantation Market



Market Overview:
Allogeneic stem cell transplantation involves transferring stem cells from a donor into a patient to replace damaged or destroyed stem cells. This process is typically used to treat blood cancers like leukemia and lymphoma as well as genetic disorders. Cord blood banking plays a crucial role in increasing the accessibility and availability of donor stem cells for transplantation procedures.

Market key trends:
The increasing prevalence of cancer diseases is a major factor driving the growth of the allogeneic stem cell transplantation market. Around 1.9 million new cancer cases are diagnosed in the U.S. annually. Moreover, the rising number of stem cell transplantation procedures performed worldwide is also propelling the growth of this market. Improving healthcare infrastructure along with growing investments to develop novel technologies in emerging countries is expected to create lucrative opportunities over the forecast period.

The global Allogeneic Stem Cell Transplantation Market Size is estimated to be valued at US$ 3.9 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global allogeneic stem cell transplantation market is segmented into stem cell sources, treatment types, indications, and end users. The stem cell sources segment is further divided into bone marrow, peripheral blood stem cells, and umbilical cord blood. Peripheral blood stem cells are the most dominant sub-segment as these cells have higher stem cell count compared to bone marrow and can be collected faster with less discomfort to the donor.

Key Takeaways
The global allogeneic stem cell transplantation market is expected to witness high growth, exhibiting a CAGR of 7.9% over the forecast period, due to increasing prevalence of hematological malignancies and cancers.

Regional analysis
North America dominated the global market in 2023, accounting for nearly 35% of global revenue, owing to increasing health expenditure and rising adoption of stem cell therapies in the region. Asia Pacific is expected to grow at the fastest rate over the forecast period due to improving healthcare infrastructure and growing medical tourism in countries like China, India, and Japan.

Key players analysis
Key players operating in the allogeneic stem cell transplantation market are Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., MEDIPOST Co., Ltd., Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Cellular Biomedicine Group, Inc., Biosolution Co., Ltd., StemCell Technologies Inc., Caladrius Biosciences, Inc., TiGenix N.V., ViaCord, Vericel Corporation, Regen Biopharma Inc., Gamida Cell Ltd., Histogenics Corporation, BrainStorm Cell Therapeutics Inc., Lineage Cell Therapeutics, Inc.


Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more